Germany, July 14 -- Evonik has partnered with global antibody expression specialist evitria to offer a ready-to-use transient protein expression kit based on CHO cells for biopharmaceutical research and development. Designed to enable faster, more reliable, and scalable protein production, the kit addresses key challenges in transient protein expression workflows. Through this collaboration, Evonik is expanding access to evitria's expertise, while strengthening its own portfolio of precision biosolutions for biopharma customers. CHO (Chinese Hamster Ovary) cells are widely used to produce proteins such as antibodies for biopharmaceutical applications. In early-stage research, scientists often use transient protein expression to produce prot...